Ben Trotman’s tumor is completely gone after participating in a clinical trial to treat glioblastoma, one of the deadliest ...

A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically ...

A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma ...

Scientists have discovered a sugar compound from deep-sea bacteria that can destroy cancer cells in a dramatic way. This natural substance, produced by microbes living in the ocean, causes cancer ...

Exposing people with similar types of breast cancer to radiation alone led to changes in tumor and immune cells, paving the ...

The Nobel Prize-winning click chemistry technology allowed researchers to target tumors directly with a chemotherapy drug, ...

Prescient Therapeutics has signalled its position as one of the most advanced oncology companies on the ASX, according to ...

DelveInsight’s Breast Cancer pipeline report depicts a robust space with 100+ Breast Cancer companies working to develop 120+ pipeline therapies for Breast Cancer treatment.

DelveInsight’s, “Metastatic Urothelial Carcinoma Pipeline Insight, 2025” report provides comprehensive insights about 40+ ...

Fraction, PDF, Vitamin C, Anticancer, Pancreatic Cancer, Cervical Cancer, Small-Cell Lung Cancer Share and Cite: Konno, S. , Penunuri, A. , Wong, J. , Fullerton, S. and Choudhury, M. (2025) Anticancer ...

A promising clinical trial shows that a combination of paxalisib, pembrolizumab, and chemotherapy significantly reduces circulating tumor cells in metastatic triple-negative breast cancer.

With a new leadership team and fast-track designation from the US Food and Drug Administration (FDA), clinical-stage oncology ...